Clinical Response in Plaque Psoriasis Patients Switching from Etanercept to Certolizumab Pegol in a Phase 3, Randomized, Controlled Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, p. S86, 2018. DOI: 10.25251/skin.2.supp.87. Disponível em: https://skin.dermsquared.com/skin/article/view/483. Acesso em: 19 apr. 2025.